Arqule

Develops cancer therapeutics using a Kinase inhibitor platform

placeWoburn, Massachusetts, United States calendar_todayFounded 1993 groups32 employees language arqule.com

Registered entities

Innovation

99 patent families (68 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport, Physics & computing; filing pace slowing. Cited 6,860 times.

YearFilings
201514
201614
201714
20188
201911
202014
202112
20225
20236
20243
20258
20261

Investor mix

9 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital444%
Private equity556%
Coming soon